![Stanley Frankel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stanley Frankel
Directeur/Membre du Conseil chez
PRECISION BIOSCIENCES, INC.
Fortune : 318 157 $ au 30/06/2026
Profil
Stanley R.
Frankel is an Independent Non-Executive Director at Precision BioSciences, Inc. since 2021.
Dr. Frankel is an Independent Director at CREATE Medicines, Inc. (Massachusetts) since 2022.
Formerly, Dr. Frankel was SVP-Global Drug Development & Cellular Therapy at Bristol Myers Squibb Co. from 2019 to 2020.
Dr. Frankel was VP, Head-Clinical Research & Development at Celgene Corp.
from 2015 to 2019.
Dr. Frankel was Chief Medical Officer at Cytovia Therapeutics, Inc. Education includes a doctorate from Northwestern University and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 40 478 ( 0,17% ) | 318 157 $ | 30/06/2026 |
Postes actifs de Stanley Frankel
| Sociétés | Poste | Début |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Directeur/Membre du Conseil | 12/04/2021 |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Directeur/Membre du Conseil | 30/06/2022 |
Anciens postes connus de Stanley Frankel
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2020 |
| CELGENE | Directeur Technique/Scientifique/R&D | 01/11/2019 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Stanley Frankel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Choisissez Zonebourse 
